Health Trials

Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis

ConditionsOsteoarthritis (OA) of the KneeKnee Pain ArthritisChronic Knee Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFUSMobile Inc.

About this trial

This study involves the use of sound waves to block pain signals caused by osteoarthritis of the knee. The sound waves are tightly focused on a specific area of the nerve. The sound waves cause a break in the nerve which carries pain signals. Sound waves transmit through the skin so there is no need for needles. The procedure takes approximately one hour. The device has been approved in Health Canada and Europe for the treatment of lower back pain. This study is to evaluate the use of the same device for people in Canada who have knee pain related to osteoarthritis.

Eligibility criteria

Qualifiers

Moderate to severe, predominantly medial chronic knee pain

Age adult >18 years old

WOMAC Score of 30 or higher

NRS>6 with ambulation

Disqualifiers

Individuals after any surgery associated with altered integrity of bone structure

Individuals with severe pain in the second knee

Individuals unable to understand and complete the research questionnaires in the official language

Individuals presenting with any severe medical condition preventing the participant from safely and effectively being treated in the study or reporting study outcomes, per PI decision

Trial design

Treatments tested in this trial

  • Neurotomy of the medial sensory articular branches

Treatment groups

10 Participants
are divided into 1 treatment group

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Unika Medical CentreRecruitingM3B3S6, North York, OntarioCanadaCanada

Sponsors and collaborators

FUSMobile Inc.

Lead sponsor

Source ClinicalTrials.gov